Related Experiment Video
Updated: Jun 12, 2025

Using the E1A Minigene Tool to Study mRNA Splicing Changes
Published on: April 22, 2021
The splicing factor QKI inhibits metastasis by modulating alternative splicing of E-Syt2 in papillary thyroid
Mengya Zhao1, Yu Jin2, Zhongyi Yan3
1Department of Head and Neck Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University & The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center Nanjing, Nanjing Medical University, Nanjing, China; Wuxi People's Hospital, Wuxi Medical Center Nanjing & Department of Immunology, School of Basic Medical Science & Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu, China; The Affiliated Huai'an No. 1 People's Hospital, Nanjing Medical University, Nanjing, China.
Abstract:
Alternative splicing (AS) plays a crucial role in the hallmarks of cancer and can open new avenues for targeted therapies. However, the aberrant AS events and the metastatic cascade in papillary thyroid carcinoma (PTC) remain largely unclear. Here, we identify the splicing factor, quaking protein (QKI), which was significantly downregulated in PTC and correlated with poor survival outcomes in patients with PTC. Functional studies indicated that low expression of QKI promoted the PTC cell growth and metastasis in vitro and in vivo. Mechanistically, low QKI induced exon 14 retention of extended synaptotagmin 2 (E-Syt2) and produced a long isoform transcript (termed E-Syt2L) that acted as an important oncogenic factor of PTC metastasis. Notably, overexpression of long non-coding RNA eosinophil granule ontogeny transcript (EGOT) physically binds to QKI and suppressed its activity by inhibiting ubiquitin specific peptidase 25 (USP25) mediated deubiquitination and subsequent degradation of QKI. Collectively, these data demonstrate the novel mechanistic links between the splicing factor QKI and splicing event in PTC metastasis and support the potential utility of targeting splicing events as a therapeutic strategy for PTC.
Insights
Quaking protein (QKI) downregulation promotes papillary thyroid carcinoma (PTC) growth and metastasis by altering splicing. Targeting QKI or its related splicing events may offer new therapeutic strategies for PTC patients.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Alternative splicing (AS) is implicated in cancer development and progression.
- Aberrant AS events contributing to papillary thyroid carcinoma (PTC) metastasis are not well understood.
Purpose of the Study:
- To investigate the role of the splicing factor quaking protein (QKI) in PTC metastasis.
- To elucidate the molecular mechanisms linking QKI to PTC progression.
Main Methods:
- Analysis of QKI expression in PTC patient samples and correlation with survival.
- In vitro and in vivo functional studies to assess the impact of QKI on PTC cell behavior.
- Mechanistic investigations involving alternative splicing of extended synaptotagmin 2 (E-Syt2) and interactions with long non-coding RNA eosinophil granule ontogeny transcript (EGOT).
Main Results:
- QKI was significantly downregulated in PTC and associated with poor patient outcomes.
- Reduced QKI expression enhanced PTC cell growth and metastasis.
- Low QKI levels induced exon 14 retention of E-Syt2, generating an oncogenic E-Syt2 long isoform (E-Syt2L).
- Overexpressed EGOT suppressed QKI activity by inhibiting USP25-mediated deubiquitination and degradation.
Conclusions:
- QKI functions as a tumor suppressor in PTC metastasis.
- The QKI/E-Syt2 splicing axis represents a novel mechanism driving PTC metastasis.
- Targeting aberrant splicing events, particularly those involving QKI, presents a potential therapeutic avenue for PTC.
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Abnormal Proliferation

